Schlumberger NV vs Twist Bioscience Corp — how do they compare? Schlumberger NV trades at $46.77 (market cap $69.36B), while Twist Bioscience Corp trades at $88.31 (market cap $5.45B). The key difference: Schlumberger NV is far larger — about 12.7× Twist Bioscience Corp's market cap, and Schlumberger NV pays a 2.54% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| SLB | TWST | |
|---|---|---|
Market Cap | $69.36B | $5.45B |
Sector | Energy | Health |
52-Week High | $58.01 | $102.88 |
52-Week Low | $31.72 | $24.16 |
Enterprise Value | $77.58B | $5.37B |
Dividend Yield | 2.54% | — |
Trailing returns across standard periods
Latest headlines on both assets
Schlumberger is the largest oilfield service firm in the world, with expertise in myriad disciplines, including reservoir performance, well construction, production enhancement, and more recently, digital solutions. It maintains a reputation as one of the industry's leading innovators, which has earned it dominant share in numerous end markets.
Read more on SLB →Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →